PAMELLA WALKER: Open Payments
NPI 1558922070 · SMITHTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 49 payments from 16 companies in 2025. Trend: 2023 $1,862 · 2024 $2,156 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $177 |
| AstraZeneca Pharmaceuticals LP | 7 | $130 |
| GENZYME CORPORATION | 3 | $102 |
| Verona Pharma, Inc. | 5 | $86 |
| Vifor Pharma, Inc. | 4 | $86 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| HARMONY BIOSCIENCES LLC | 2 | $44 |
| Grifols USA, LLC | 2 | $44 |
Products named: DUPIXENT, NUCALA, Ohtuvayre, Zemaira, TRELEGY ELLIPTA, AIRSUPRA, TEZSPIRE, OFEV.
Industry payments across NY — which companies pay providers there.
